CrushSCI.com
提供学术论文选刊润色服务
Immunotherapy 期刊封面 医学
返回期刊列表

Review Cycle Records

Immunotherapy

Taylor & Francis SCIE 非OA
2026新锐 3区2025中科院 4区2025 JCR Q3
143.2平均天数
133中位天数
43最短天数
257最长天数
1352025发文量

Paper Review Records

全部论文审稿周期

14 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

182 天

Impact of immunotherapy in the treatment of early-stage non-small lung cancer, melanoma, and colorectal cancer

作者Alfredo Tartarone; Raffaele Conca; Alessandra Perrone; Rosa Lerose

作者单位1. IRCCS-CROB Referral Cancer Center of Basilicata

PDF源文件 DOI 网页
137 天

Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectives

作者Aditya Raj; Zuber Khan; Mumtaz; Sidharth Mehan; Tapan Lamba; Niyati Pandoh; Keerti Dayal

作者单位1. ISF College of Pharmacy (An Autonomous College); 2. ISF College of Pharmacy (Affiliated to IK Gujral Punjab Technical University, Jalandhar); 3. School of Pharmaceutical Education and Research

PDF源文件 DOI 网页
128 天

The role of artificial intelligence in predicting immunotherapy treatment outcomes based on gut microbiota composition in cancer patients: a meta-analysis

作者Leen Alhassan; Bassel Alrabadi; Suhel F. Batarseh; Yousef Alghzawi; Natalie Bandak; Aseel Badwan; Hadeel Al kayed

作者单位1. Jordan University of Science and Technology; 2. University of Jordan; 3. WellStar Cobb Hospital

PDF源文件 DOI 网页
65 天

Making dietary modification in the immunotherapy Era: from mechanistic evidence to practical implementation

作者Parham Habibzadeh; Drew Hurd; Diwakar Davar

作者单位1. University of Pittsburgh Medical Center; 2. University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center; 3. University of Pittsburgh

PDF源文件 DOI 网页
129 天

Cost-effectiveness analysis of Nivolumab plus Ipilimumab versus Nivolumab monotherapy in previously treated metastatic colorectal cancer patients with DNA mismatch repair-deficient/microsatellite instability-high (dMMR/MSI-H) in China

作者Xiaohong Zhu; Xu Yang; Tong Liu

作者单位1. Harbin Medical University Cancer Hospital

PDF源文件 DOI 网页
43 天

Safety and tolerability of a new intravenous immunoglobulin 10% in patients with primary immunodeficiency

作者Roberto Crea; Elena Perez; Chaim M. Roifman

作者单位1. Kedrion S.p.A; 2. Allergy Associates of the Palm Beaches; 3. Hospital for Sick Children

PDF源文件 DOI 网页
257 天

Impact of sublingual immunotherapy with dust mite drops on ECP, TARC, VCAM-1 inflammatory status in patients with allergic rhinitis

作者Bangyu Deng; Yunxia Zhao; Jisheng Liu

作者单位1. The Affiliated Suzhou Hospital of Nanjing Medical University; 2. Suzhou Jinji Lake Health Service Center; 3. The First Affiliated Hospital of Soochow University

PDF源文件 DOI 网页
91 天

Lupus nephritis treatment: a comprehensive overview of recent meta-analyses and future directions

作者Feigao Li; Xizhe Liu; Bokun Chen; Menghao Li; Xiuju Liu

作者单位1. The Second Hospital of Hebei Medical University; 2. The Third Hospital of Hebei Medical University; 3. Hebei Medical University

PDF源文件 DOI 网页
199 天

Modified Dendritic cells as a therapeutic platform in hematologic malignancies with translational insights from central nervous system tumors

作者Mahsa Akbari Oryani; Hossein Tabarsa; Ghazaleh Hatamian; Mahboubeh Tajaldini; Hossein Javid; Ali Mehri; Mehdi Karimi-Shahri

作者单位1. Mashhad University of Medical Sciences; 2. Mazandaran University of Medical Sciences; 3. Shahid Beheshti University; 4. Golestan University of Medical Sciences; 5. Varastegan Institute for Medical Sciences; 6. Gonabad University of Medical Sciences

PDF源文件 DOI 网页
201 天

The long-term effectiveness of specific immunotherapy in cat allergy: a real-life study

作者Nilay Orak Akbay; Dilşad Mungan; Betül Ayşe Sin

作者单位1. Ankara Etlik City Hospital; 2. Ankara University School of Medicine

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。